(Q81696029)
English
Open-label, non-randomised, inter-individual dose escalation of ZK 304709 with the evaluation of safety, tolerability, pharmacokinetics, oral bioavailability and orientating efficacy after daily administration in patients with advanced cancer (7 d t
scientific article published on 22 July 2008
Statements
Open-label, non-randomised, inter-individual dose escalation of ZK 304709 with the evaluation of safety, tolerability, pharmacokinetics, oral bioavailability and orientating efficacy after daily administration in patients with advanced cancer (7 d treatment and 14 d recovery) (English)
Janet S Graham
Ruth Plummer
Candice McCoy
Kristin Kowal
Herbert Wiesinger
Katharina Detjen
Hilary Calvert
Bertram Wiedenmann